Moroctocog Alfa (AF-CC) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Hemophilia A in India
ConclusionMoroctocog alfa was safe, effective, and well tolerated in Indian participants with congenital moderate to severe hemophilia A. No participant developed FVIII inhibitors during the study.
Source: Indian Journal of Hematology and Blood Transfusion - Category: Hematology Source Type: research
More News: Bleeding | Blood Transusion | Haemophilia | Hematology | Hemophilia | India Health | Study